Researchers have identified why statins, widely prescribed cholesterol-lowering drugs, can trigger muscle pain, weakness, and damage in some patients. Using advanced imaging technology, scientists discovered that statins attach to a crucial protein in muscle cells and force open a calcium channel. This causes calcium to leak continuously from the channel, potentially harming muscle tissue.
Statins work by reducing cholesterol levels, helping prevent heart attacks and strokes. However, a subset of patients experience statin-related muscle side effects, a condition known as statin-associated muscle symptoms. The mechanism behind these adverse effects remained unclear until this research.
The discovery centers on how statins interact with muscle cell proteins. When statins bind to the protein, they abnormally open a channel responsible for regulating calcium flow. Rather than functioning normally, the channel remains open, allowing calcium to escape continuously into muscle cells. Excess calcium accumulation in muscle tissue disrupts normal cellular function and can lead to muscle damage.
This finding explains why some patients report muscle pain and weakness after beginning statin therapy. The severity varies among individuals, with some experiencing mild discomfort and others developing severe muscle damage requiring discontinuation of the medication.
The research used advanced imaging techniques to visualize how statins interact with muscle cell proteins at a molecular level. This detailed examination revealed the precise mechanism of statin-induced muscle injury, providing the scientific foundation for understanding statin-related side effects.
Understanding this mechanism could help researchers develop strategies to prevent or reduce statin-related muscle complications while maintaining the cardiovascular benefits these drugs provide. The findings may also inform discussions between doctors and patients about statin therapy, particularly for those at risk of muscle-related side effects.